Sunflower Pharmaceuticals Group Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 22.45%

Sunflower Pharmaceuticals Group Co Ltd (002737) has an Asset Resilience Ratio of 22.45% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 002737 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥1.20 Billion

≈ $175.97 Million USD Cash + Short-term Investments

Total Assets

CN¥5.36 Billion

≈ $783.70 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Sunflower Pharmaceuticals Group Co Ltd's Asset Resilience Ratio has changed over time. See Sunflower Pharmaceuticals Group Co Ltd (002737) balance sheet quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Sunflower Pharmaceuticals Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 002737 market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.20 Billion	22.45%
Total Liquid Assets	CN¥1.20 Billion	22.45%

Asset Resilience Insights

Good Liquidity Position: Sunflower Pharmaceuticals Group Co Ltd maintains a healthy 22.45% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Sunflower Pharmaceuticals Group Co Ltd Industry Peers by Asset Resilience Ratio

Compare Sunflower Pharmaceuticals Group Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Aurobindo Pharma Limited NSE:AUROPHARMA	Drug Manufacturers - Specialty & Generic	1.28%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Tianjin Chase Sun Pharmaceutical Co Ltd SHE:300026	Drug Manufacturers - Specialty & Generic	-0.89%
Zhejiang Hisoar Pharmaceutical Co Ltd SHE:002099	Drug Manufacturers - Specialty & Generic	0.20%
Xeris Pharmaceuticals Inc NASDAQ:XERS	Drug Manufacturers - Specialty & Generic	0.00%
Procter & Gamble Health Limited NSE:PGHL	Drug Manufacturers - Specialty & Generic	33.01%

Annual Asset Resilience Ratio for Sunflower Pharmaceuticals Group Co Ltd (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Sunflower Pharmaceuticals Group Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	32.94%	CN¥1.76 Billion ≈ $256.85 Million	CN¥5.33 Billion ≈ $779.70 Million	+11.34pp
2024-12-31	21.60%	CN¥1.26 Billion ≈ $184.12 Million	CN¥5.83 Billion ≈ $852.51 Million	+2.49pp
2023-12-31	19.11%	CN¥1.32 Billion ≈ $192.44 Million	CN¥6.88 Billion ≈ $1.01 Billion	-1.49pp
2022-12-31	20.60%	CN¥1.45 Billion ≈ $211.99 Million	CN¥7.03 Billion ≈ $1.03 Billion	+8.74pp
2021-12-31	11.87%	CN¥668.69 Million ≈ $97.85 Million	CN¥5.64 Billion ≈ $824.61 Million	+8.92pp
2020-12-31	2.94%	CN¥150.49 Million ≈ $22.02 Million	CN¥5.11 Billion ≈ $748.24 Million	-0.92pp
2019-12-31	3.86%	CN¥205.00 Million ≈ $30.00 Million	CN¥5.31 Billion ≈ $776.92 Million	-0.95pp
2018-12-31	4.81%	CN¥243.46 Million ≈ $35.63 Million	CN¥5.06 Billion ≈ $740.31 Million	-0.87pp
2017-12-31	5.68%	CN¥254.00 Million ≈ $37.17 Million	CN¥4.47 Billion ≈ $654.13 Million	-0.43pp
2016-12-31	6.11%	CN¥258.00 Million ≈ $37.75 Million	CN¥4.22 Billion ≈ $618.05 Million	--

pp = percentage points

About Sunflower Pharmaceuticals Group Co Ltd

SHE:002737 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.06 Billion

CN¥7.25 Billion CNY

Market Cap Rank

#8839 Global

#2219 in China

Share Price

CN¥12.41

Change (1 day)

-1.35%

52-Week Range

CN¥11.89 - CN¥16.74

All Time High

CN¥28.79